OmanDocSign in

Curriculum · Toxicology and Emergency Care

Anticholinergic toxicity with wide-complex tachycardia

What it is

The anticholinergic toxidrome comes from low potency antipsychotics, oxybutynin, ACh receptor antagonists such as Ipratropium, Atropine and Scopolamine, TCA and antihistamines.

How it presents

The picture is hot as a desert for the hyperthermia, blind as a bat for the dilated pupils of mydriasis, mad as a hatter for the confusion, dry as a bone for the dry mouth and urinary retention, and red as a beet for the flushed skin. Tachycardia, absent bowel sounds, shaking and grabbing at invisible objects go with them.

Not every case opens with that list. A 23 years old woman brought to the emergency department because she was vague and confused, with a past medical history of depression and medications prescribed 2 months ago that she was not using regularly, may show only an HR of 114 that is regular, a T of 37, a BP of 102/65, a Sat of 99% on RA and an RR of 18. The tachycardia and the confusion carry the case, and the drug history is the rest of it.

How it is treated

A tachycardia with a pulse is first assessed for appropriateness for the clinical condition; the heart rate is typically 150/min or more if the rhythm is a tachyarrhythmia. Identify and treat the underlying cause: maintain the airway and assist breathing as necessary, give oxygen as indicated, and use a cardiac monitor to identify the rhythm while monitoring blood pressure and oximetry.

The point of decision is whether the tachyarrhythmia is persistent and causing hypotension, acute confusion, signs of shock, ischemic chest discomfort or acute heart failure. If it is, the answer is synchronized cardioversion, with sedation considered, and if the complex is regular and narrow, adenosine may be considered. Initial recommended doses are 50 to 100 J for narrow regular, 120 to 200 J biphasic or 200 J monophasic for narrow irregular, 100 J for wide regular, and a defibrillation dose, not synchronized, for wide irregular.

If the tachyarrhythmia is not causing any of those, the next question is whether the QRS is wide at 0.12 second, and the two arms are not the same. If the QRS is wide: IV access and a 12-lead ECG if available, adenosine considered only if the rhythm is regular and monomorphic, an antiarrhythmic infusion considered, and expert consultation considered. If the QRS is not wide: IV access and a 12-lead ECG if available, vagal maneuvers, adenosine if the rhythm is regular, a beta-blocker or calcium channel blocker, and expert consultation. Adenosine is 6 mg by rapid IV push followed by an NS flush, with a second dose of 12 mg if required.

For a stable wide-QRS tachycardia the antiarrhythmic infusions are:

Lidocaine, adenosine and procainamide may be used for the initial treatment of a wide-complex tachycardia of uncertain type. Pulseless VT is a different problem and is treated the same as ventricular fibrillation: defibrillation first, and if that is unsuccessful, epinephrine and defibrillation again. Synchronized cardioversion alone is for rapid unstable tachycardia with a pulse.

Where the toxidrome comes from a tricyclic antidepressant the steps are set out in order, and the seizure has a line of its own. Tricyclic antidepressant toxicity presents with the three Cs, coma, convulsions and cardiac conduction abnormalities, and a QRS above 0.12 sec is a better predictor of toxicity than the serum drug level. The treatment then runs: rapid sequence intubation for a GCS less than 8 or a compromised airway; gastric lavage and activated charcoal only where the ingestion was less than 1 h ago; broad QRS complexes with a positive R’ wave in aVR meaning a high risk of complication, so vitals are monitored; and for the seizure, benzodiazepines, and phenytoin is not to be given. So a patient with broad QRS complexes whose ingestion was more than 1 h ago is past both the lavage and the charcoal, and the convulsion is treated with the benzodiazepine.